MBIO - What's Going On With Mustang Bio Stock Tuesday? | Benzinga
Mustang Bio, Inc. (NASDAQ:MBIO) shares appear to be trending upward Tuesday on continued momentum after the company on Monday announced safety and efficacy data from its Phase 1/2 clinical trial of MB-106, a possible treatment for certain types of blood cancer.
90% ...